These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 1707960)
1. Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry. Piggott NH; Henry JA; May FE; Westley BR J Pathol; 1991 Feb; 163(2):95-104. PubMed ID: 1707960 [TBL] [Abstract][Full Text] [Related]
2. Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells. May FE; Westley BR J Pathol; 1997 Aug; 182(4):404-13. PubMed ID: 9306961 [TBL] [Abstract][Full Text] [Related]
3. Expression of the pNR-2/pS2 protein in diverse human epithelial tumours. Henry JA; Bennett MK; Piggott NH; Levett DL; May FE; Westley BR Br J Cancer; 1991 Oct; 64(4):677-82. PubMed ID: 1911216 [TBL] [Abstract][Full Text] [Related]
4. pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response. Henry JA; Piggott NH; Mallick UK; Nicholson S; Farndon JR; Westley BR; May FE Br J Cancer; 1991 Apr; 63(4):615-22. PubMed ID: 1850611 [TBL] [Abstract][Full Text] [Related]
5. Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy. Henry JA; Nicholson S; Hennessy C; Lennard TW; May FE; Westley BR Br J Cancer; 1990 Jan; 61(1):32-8. PubMed ID: 2153395 [TBL] [Abstract][Full Text] [Related]
6. The pS2 gene, mRNA, and protein: a potential marker for human breast cancer. Rio MC; Chambon P Cancer Cells; 1990; 2(8-9):269-74. PubMed ID: 2223388 [TBL] [Abstract][Full Text] [Related]
7. Cloning of estrogen-regulated messenger RNA sequences from human breast cancer cells. May FE; Westley BR Cancer Res; 1986 Dec; 46(12 Pt 1):6034-40. PubMed ID: 2430688 [TBL] [Abstract][Full Text] [Related]
8. Determination of oestrogen responsiveness of breast cancer by competitive reverse transcription-polymerase chain reaction. Carr M; May FE; Lennard TW; Westley BR Br J Cancer; 1995 Dec; 72(6):1427-34. PubMed ID: 8519655 [TBL] [Abstract][Full Text] [Related]
9. Production and comparison of mature single-domain 'trefoil' peptides pNR-2/pS2 Cys58 and pNR-2/pS2 Ser58. Chadwick MP; May FE; Westley BR Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):1001-7. PubMed ID: 8948462 [TBL] [Abstract][Full Text] [Related]
10. Expression and localization of homeodomain proteins DLX4/HB9 in normal and malignant human breast tissues. Neufing PJ; Kalionis B; Horsfall DJ; Ricciardelli C; Stahl J; Vivekanandan S; Raymond W; Tilley WD Anticancer Res; 2003; 23(2B):1479-88. PubMed ID: 12820413 [TBL] [Abstract][Full Text] [Related]
11. Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer. Van Beijnum JR; Moerkerk PT; Gerbers AJ; De Bruïne AP; Arends JW; Hoogenboom HR; Hufton SE Int J Cancer; 2002 Sep; 101(2):118-27. PubMed ID: 12209988 [TBL] [Abstract][Full Text] [Related]
12. Production and characterization of monoclonal antibodies recognising defined regions of the human oestrogen receptor. Ali S; Lutz Y; Bellocq JP; Chenard-Neu MP; Rouyer N; Metzger D Hybridoma; 1993 Aug; 12(4):391-405. PubMed ID: 7503939 [TBL] [Abstract][Full Text] [Related]
13. Polyclonal antibodies against gp185HER2 peptides: their putative role in the identification of a particular HER2 status in patients with breast cancer. Di Modugno F; Buglioni S; Mottolese M; Bello DD; Cascioli S; Chersi A; Santoni A; Nisticò P J Immunother; 2001; 24(3):221-31. PubMed ID: 11394499 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Liu XL; Wazer DE; Watanabe K; Band V Cancer Res; 1996 Jul; 56(14):3371-9. PubMed ID: 8764136 [TBL] [Abstract][Full Text] [Related]
15. Expression of the pS2 peptide in primary breast carcinomas: comparison of membrane and cytoplasmic staining patterns. Dookeran KA; Rye PD; Dearing SJ; Walker RA J Pathol; 1993 Oct; 171(2):123-9. PubMed ID: 8283349 [TBL] [Abstract][Full Text] [Related]
16. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer. Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777 [TBL] [Abstract][Full Text] [Related]
18. A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections. Wang X; Campoli M; Cho HS; Ogino T; Bandoh N; Shen J; Hur SY; Kageshita T; Ferrone S J Immunol Methods; 2005 Apr; 299(1-2):139-51. PubMed ID: 15896802 [TBL] [Abstract][Full Text] [Related]
19. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene. Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813 [TBL] [Abstract][Full Text] [Related]
20. Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody. Hnatyszyn HJ; Liu M; Hilger A; Herbert L; Gomez-Fernandez CR; Jorda M; Thomas D; Rae JM; El-Ashry D; Lippman ME Breast Cancer Res Treat; 2010 Jul; 122(2):371-80. PubMed ID: 19842031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]